Microba Life Sciences Limited (ASX:MAP)
Australia · Delayed Price · Currency is AUD 0.0400
+0.0010 (2.56%)
Jun 26, 2026, 4:10 PM AEST
Microba Life Sciences Market Cap
Microba Life Sciences has a market cap or net worth of 24.36 million as of June 26, 2026. Its market cap has decreased by -63.74% in one year.
Market Cap
24.36M
Enterprise Value
15.63M
Revenue
14.90M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.04
Market Cap Chart
Since April 5, 2022, Microba Life Sciences's market cap has decreased from 96.03M to 24.36M, a decrease of -74.63%. That is a compound annual growth rate of -27.71%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 26, 2026 | 24.36M | -47.37% |
| Dec 31, 2025 | 46.28M | -47.00% |
| Dec 31, 2024 | 87.33M | 8.33% |
| Dec 29, 2023 | 80.61M | -29.31% |
| Dec 30, 2022 | 114.03M | 18.75% |
| Apr 5, 2022 | 96.03M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Australian Clinical Labs | 411.86M |
| Monash IVF Group | 276.64M |
| Healius | 265.04M |
| INOVIQ | 76.72M |
| Cryosite | 56.13M |
| Rhythm Biosciences | 35.39M |
| BCAL Diagnostics | 28.76M |
| ImExHS | 16.49M |